CY2271B1 - 1.(1,2-disubstituted piperidinyl)-4-(fused imidazole)-piperidine derivatives - Google Patents

1.(1,2-disubstituted piperidinyl)-4-(fused imidazole)-piperidine derivatives

Info

Publication number: CY2271B1
Authority: CY; Cyprus
Prior art keywords: piperidine derivatives; fused imidazole; disubstituted piperidinyl; disubstituted; piperidinyl
Prior art date: 1995-12-27

Application number

CY0200023A

Other languages

English (en)

Inventor

Frans Eduard Janssens

Joseph Elisabeth Leenaerts

Van Yves Emiel Mari Roosbroeck

Original Assignee

Janssen Pharmaceutica Nv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-12-27

Filing date

2002-04-25

Publication date

2003-07-04

2002-04-25 Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv

2003-07-04 Publication of CY2271B1 publication Critical patent/CY2271B1/xx

Links

150000002460 imidazoles Chemical class 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
- C07D487/14—Ortho-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/20—Spiro-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D495/14—Ortho-condensed systems

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Virology (AREA)
Pulmonology (AREA)
Dermatology (AREA)
Immunology (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Molecular Biology (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Hospice & Palliative Care (AREA)
Physical Education & Sports Medicine (AREA)
Orthopedic Medicine & Surgery (AREA)
Otolaryngology (AREA)
Biotechnology (AREA)
Anesthesiology (AREA)
Urology & Nephrology (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

CY0200023A 1995-12-27 2002-04-25 1.(1,2-disubstituted piperidinyl)-4-(fused imidazole)-piperidine derivatives CY2271B1 (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
EP95203652		1995-12-27

Publications (1)

Publication Number	Publication Date
CY2271B1 true CY2271B1 (en)	2003-07-04

Family

ID=8221024

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CY0200023A CY2271B1 (en)	1995-12-27	2002-04-25	1.(1,2-disubstituted piperidinyl)-4-(fused imidazole)-piperidine derivatives

Country Status (29)

Country	Link
US (1)	US6251894B1 (de)
EP (1)	EP0843679B1 (de)
JP (1)	JP4097043B2 (de)
KR (1)	KR100485147B1 (de)
CN (1)	CN1066733C (de)
AR (2)	AR005278A1 (de)
AT (1)	ATE208392T1 (de)
AU (1)	AU716071B2 (de)
BR (1)	BR9612307A (de)
CA (1)	CA2238817C (de)
CY (1)	CY2271B1 (de)
CZ (1)	CZ295861B6 (de)
DE (1)	DE69616802T2 (de)
DK (1)	DK0843679T3 (de)
EA (1)	EA001374B1 (de)
ES (1)	ES2167619T3 (de)
HU (1)	HU229766B1 (de)
IL (2)	IL124642A (de)
MY (1)	MY117680A (de)
NO (1)	NO310916B1 (de)
NZ (1)	NZ325845A (de)
PL (1)	PL183767B1 (de)
PT (1)	PT843679E (de)
SI (1)	SI0843679T1 (de)
SK (1)	SK283540B6 (de)
TR (1)	TR199801210T2 (de)
TW (1)	TW382017B (de)
WO (1)	WO1997024356A1 (de)
ZA (1)	ZA9610889B (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
TW527186B (en) *	1996-03-19	2003-04-11	Janssen Pharmaceutica Nv	Fused imidazole derivatives as multidrug resistance modulators
ATE233104T1 (de)	1997-09-18	2003-03-15	Janssen Pharmaceutica Nv	Kondensierte imidazolderivate zur erhöhung der oralen bioverfügbarkeit von pharmazeutika
BR9916371A (pt) *	1998-12-19	2001-09-18	Janssen Pharmaceutica Nv	Composto de espiro anti-histamìnico
WO2001030348A1 (en) *	1999-10-25	2001-05-03	Janssen Pharmaceutica N.V.	Use of substance p antagonists for influencing the circadian timing system
CA2448735C (en)	2001-06-12	2008-10-28	Janssen Pharmaceutica N.V.	Novel substituted tetracyclic imidazole derivatives, processes for their preparation, pharmaceutical compositions comprising them and their use as a medicine
US20030083345A1 (en) *	2001-07-10	2003-05-01	Torsten Hoffmann	Method of treatment and/or prevention of brain, spinal or nerve injury
AU2002356715B2 (en) *	2001-11-23	2008-05-15	Janssen Pharmaceutica N.V.	The use of anti-histaminics for acute reduction of elevated intracranial pressure
EP1457493A4 (de) *	2001-12-10	2005-11-30	Kyorin Seiyaku Kk	Kondensierte, bicyclische pyridin derivate als tachykininrezeptorantagonisten
DE60300683T2 (de) *	2002-01-16	2006-04-27	Janssen Pharmaceutica N.V.	Prucaloprid-n-oxid
ATE427310T1 (de)	2002-01-18	2009-04-15	Kyorin Seiyaku Kk	Kondensierte bicyclische pyrimidinderivate
KR20040099367A (ko)	2002-03-26	2004-11-26	교린 세이야꾸 가부시키 가이샤	타키키닌 수용체 길항제로서의 축합 바이사이클릭 피리딘 유도체
WO2004056805A1 (en) *	2002-12-23	2004-07-08	Janssen Pharmaceutica N.V.	Substituted 4-(4-piperidin-4-yl-piperazin-1-yl)-azepane derivatives and their use as neurokinin antagonists
JO2696B1 (en)	2002-12-23	2013-03-03	شركة جانسين فارماسوتيكا ان. في	Derivatives of 1-piperdine-4-yl-4-biprolidine-3-yl-piperazine substituted and used as quinine antagonists
JO2676B1 (en)	2004-04-06	2012-06-17	جانسين فارماسوتيكا ان. في	Derivatives of second-aza-spiro- (5,4) -dikan and their use as antihistamines
JO2525B1 (en) *	2004-04-08	2010-03-17	شركة جانسين فارماسوتيكا ان. في	Derived 4-alkyl-and-4-canoelperidine derivatives and their use as anti-neroquin
KR101355064B1 (ko)	2005-03-03	2014-01-24	얀센 파마슈티카 엔.브이.	치환된 옥사-디아자-스피로-[5.5]-운데카논 유도체 및뉴로키닌 길항제로서의 이의 용도
ATE478075T1 (de)	2005-03-08	2010-09-15	Janssen Pharmaceutica Nv	Diazaspiro-ä4,4ü-nonanderivate als neurokinin- (nk1)-antagonisten
WO2009009829A1 (en) *	2007-07-19	2009-01-22	Adelaide Research & Innovation Pty Ltd	Method for reducing intracranial pressure
UA105182C2 (ru)	2008-07-03	2014-04-25	Ньюрексон, Інк.	Бензоксазины, бензотиазины и родственные соединения, которые имеют ингибирующую nos активность
WO2013004766A1 (en)	2011-07-04	2013-01-10	Ferrari Giulio	Nk-1 receptor antagonists for treating corneal neovascularisation
CN111918647A (zh)	2018-02-26	2020-11-10	圣拉斐尔医院有限公司	用于治疗眼痛的nk-1拮抗剂
WO2021180885A1 (en)	2020-03-11	2021-09-16	Ospedale San Raffaele S.R.L.	Treatment of stem cell deficiency

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4329353A (en)	1980-10-22	1982-05-11	Janssen Pharmaceutica, N.V.	1-(4-Aryl-cyclohexyl)piperidine derivatives, method of use thereof and pharmaceutical compositions thereof
ATE124045T1 (de) *	1990-10-10	1995-07-15	Schering Corp	Substituierte imidazobenzazepine und imidazopyridoazepine.
IL101851A (en) *	1991-06-13	1996-05-14	Janssen Pharmaceutica Nv	10-(4-piperidinyl- and piperidinylidene)-imidazo [1,2-a] (pyrrolo thieno or furano) [2,3] azepine derivatives their preparation and pharmaceutical compositions containing them and certain novel intermediates therefor
IL101850A (en) *	1991-06-13	1996-01-31	Janssen Pharmaceutica Nv	11-(4-Piperidinyl)-imidazo (2,1-b) (3) benzazepine derivatives their preparation and pharmaceutical compositions containing them
KR100346802B1 (ko) *	1993-07-13	2002-11-29	얀센 파마슈티카 엔.브이.	항앨러지성이미다조아제핀
TW397831B (en)	1994-07-15	2000-07-11	Meiji Seika Kaisha	The anti-platelet-agglutination hexahydrogenated pyridine and its derivatives
NZ321575A (en)	1995-10-30	1999-05-28	Janssen Pharmaceutica Nv	1-(1,2-disubstituted piperidinyl)-4- substituted piperazine derivatives

1996
- 1996-12-13 TW TW085115390A patent/TW382017B/zh not_active IP Right Cessation
- 1996-12-20 SI SI9630419T patent/SI0843679T1/xx unknown
- 1996-12-20 BR BR9612307A patent/BR9612307A/pt not_active IP Right Cessation
- 1996-12-20 EP EP96944693A patent/EP0843679B1/de not_active Expired - Lifetime
- 1996-12-20 CN CN96199396A patent/CN1066733C/zh not_active Expired - Fee Related
- 1996-12-20 AU AU13086/97A patent/AU716071B2/en not_active Ceased
- 1996-12-20 AT AT96944693T patent/ATE208392T1/de active
- 1996-12-20 PL PL96327136A patent/PL183767B1/pl unknown
- 1996-12-20 CZ CZ19981865A patent/CZ295861B6/cs not_active IP Right Cessation
- 1996-12-20 JP JP52403397A patent/JP4097043B2/ja not_active Expired - Fee Related
- 1996-12-20 CA CA002238817A patent/CA2238817C/en not_active Expired - Fee Related
- 1996-12-20 SK SK830-98A patent/SK283540B6/sk unknown
- 1996-12-20 WO PCT/EP1996/005885 patent/WO1997024356A1/en not_active Ceased
- 1996-12-20 IL IL12464296A patent/IL124642A/en not_active IP Right Cessation
- 1996-12-20 ES ES96944693T patent/ES2167619T3/es not_active Expired - Lifetime
- 1996-12-20 DE DE69616802T patent/DE69616802T2/de not_active Expired - Lifetime
- 1996-12-20 DK DK96944693T patent/DK0843679T3/da active
- 1996-12-20 NZ NZ325845A patent/NZ325845A/xx not_active IP Right Cessation
- 1996-12-20 EA EA199800603A patent/EA001374B1/ru not_active IP Right Cessation
- 1996-12-20 TR TR1998/01210T patent/TR199801210T2/xx unknown
- 1996-12-20 IL IL12464196A patent/IL124641A/en not_active IP Right Cessation
- 1996-12-20 PT PT96944693T patent/PT843679E/pt unknown
- 1996-12-20 HU HU9903948 patent/HU229766B1/hu not_active IP Right Cessation
- 1996-12-20 KR KR10-1998-0704830A patent/KR100485147B1/ko not_active Expired - Fee Related
- 1996-12-23 ZA ZA9610889A patent/ZA9610889B/xx unknown
- 1996-12-26 AR ARP960105895A patent/AR005278A1/es active IP Right Grant
- 1996-12-27 MY MYPI96005516A patent/MY117680A/en unknown
1998
- 1998-05-27 NO NO19982405A patent/NO310916B1/no not_active IP Right Cessation
- 1998-06-22 US US09/102,136 patent/US6251894B1/en not_active Expired - Lifetime
2002
- 2002-04-25 CY CY0200023A patent/CY2271B1/xx unknown
2005
- 2005-12-16 AR ARP050105316A patent/AR051817A2/es active IP Right Grant

Also Published As

Publication number	Publication date
IL124642A0 (en)	1998-12-06
US6251894B1 (en)	2001-06-26
DE69616802D1 (de)	2001-12-13
DE69616802T2 (de)	2002-07-04
CZ186598A3 (cs)	1998-11-11
AR005278A1 (es)	1999-04-28
CA2238817C (en)	2006-10-17
PL183767B1 (pl)	2002-07-31
ATE208392T1 (de)	2001-11-15
CA2238817A1 (en)	1997-07-10
BR9612307A (pt)	1999-07-13
WO1997024356A1 (en)	1997-07-10
ZA9610889B (en)	1998-06-23
JP2000506503A (ja)	2000-05-30
IL124641A (en)	2001-11-25
NO982405L (no)	1998-08-19
CN1206417A (zh)	1999-01-27
DK0843679T3 (da)	2002-02-25
AR051817A2 (es)	2007-02-14
HUP9903948A3 (hu)	2000-04-28
CZ295861B6 (cs)	2005-11-16
SI0843679T1 (en)	2002-06-30
SK83098A3 (en)	1999-01-11
SK283540B6 (sk)	2003-09-11
PT843679E (pt)	2002-04-29
JP4097043B2 (ja)	2008-06-04
HUP9903948A2 (hu)	2000-03-28
CN1066733C (zh)	2001-06-06
EA199800603A1 (ru)	1998-12-24
NO982405D0 (no)	1998-05-27
EP0843679B1 (de)	2001-11-07
KR100485147B1 (ko)	2005-09-13
KR19990076715A (ko)	1999-10-15
IL124642A (en)	2002-08-14
EA001374B1 (ru)	2001-02-26
ES2167619T3 (es)	2002-05-16
HU229766B1 (hu)	2014-06-30
MY117680A (en)	2004-07-31
HK1011206A1 (en)	1999-07-09
NZ325845A (en)	1999-06-29
TR199801210T2 (xx)	1999-10-21
AU716071B2 (en)	2000-02-17
IL124641A0 (en)	1998-12-06
NO310916B1 (no)	2001-09-17
PL327136A1 (en)	1998-11-23
AU1308697A (en)	1997-07-28
EP0843679A1 (de)	1998-05-27
TW382017B (en)	2000-02-11

Publication	Publication Date	Title
ZA9610885B (en)	1998-06-23	1-(1,2-disubstituted piperidinyl)-4-substituted piperidine derivatives.
CY2271B1 (en)	2003-07-04	1.(1,2-disubstituted piperidinyl)-4-(fused imidazole)-piperidine derivatives
ZA969090B (en)	1998-04-29	1-(1,2-disubstituted piperidinyl)-4-substituted piperazine derivatives.
TR199600930A2 (tr)	1997-06-21	Kristal yapida (R)-(-)-2-{N-£4-(1,1-dioksido-3-okzo-2, 3-dihidrobenzizotiazol-2-il)-butil\|- aminometil}-kroman hidroklorür.
EG23791A (en)	2007-08-13	1-(4-(1-4-Fluorophenyl-1H-indole-3-yl-1-butyl spiro (isobenzofuran 1-(3H), 4-Piperidine) hydrohalogenides
ZA962755B (en)	1997-10-06	1,3-dihydro-1-(phenylalkenyl)-2H-imidazol-2-one derivatives.
ZA200007253B (en)	2002-06-07	Process for preparing 1,4-dihydropyridine compounds.
IL126989A0 (en)	1999-09-22	Process for making 4,6-dihydroxypyrimidine
GB2297749B (en)	1998-07-01	1-[2-(substituted vinyl)]-3-4--dihydro-5h-2,3-benzodiazepine derivatives
ZA200101830B (en)	2002-06-05	Piperidine derivatives.
HU9202914D0 (en)	1992-11-30	4-(4-(4-hydroxiphenyl)-1-piperazinyl)-5-methyl-3h-1,2,4-triazole-3-one derivatives
ZA9610894B (en)	1998-06-23	1-(1,2-disubstituted piperidinyl)-4-(benzimidazolyl- and imidazopyridinyl)-piperidine derivatives.
AU6086998A (en)	1998-09-29	Process for preparing 1,4-disubstituted piperidine compounds
ZA983797B (en)	1999-11-17	Substituted 4-(3-alkenylbenzoyl)pyrazoles.
HUP9701335A3 (en)	1999-10-28	Process for producing 1-(3,4-dimethoxy-phenol)-ethanol
GB2297750B (en)	1998-07-01	1-[2-(Substituted vinyl)]-5h-2,3-benzodiazepine derivatives
ZA962754B (en)	1997-10-06	1,3-dihydro-1-(phenylalkyl)-2H-imidazol-2-one derivatives.
ZA976813B (en)	1998-02-11	Fluorinep-containing 1,4-disubstituted piperidine derivatives.
ZA982707B (en)	1999-10-20	1,4-substituted cyclic amine derivative.
SI0765311T1 (en)	2001-02-28	4-aryl-1-(indanmethyl, dihydrobenzofuranmethyl or dihydrobenzothiophenemethyl)piperidines, tetrahydropyridines or piperazines
HU210820A9 (en)	1995-08-28	1,2,3,6-tetrahydropyridine derivatives
CS457790A3 (en)	1992-04-15	Process for preparing 4-(1-methyl-4-piperidyl)-4,9-dihydrothiene (2,3-c)-benzothiepin-4-ole